BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17660490)

  • 1. Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients.
    Mandalà M; Reni M; Cascinu S; Barni S; Floriani I; Cereda S; Berardi R; Mosconi S; Torri V; Labianca R
    Ann Oncol; 2007 Oct; 18(10):1660-5. PubMed ID: 17660490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
    Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
    Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
    Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
    Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study.
    Kim JS; Kang EJ; Kim DS; Choi YJ; Lee SY; Kim HJ; Seo HY; Kim JS
    BMC Cancer; 2018 Dec; 18(1):1260. PubMed ID: 30558603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
    Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
    Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous Thromboembolism in Patients with Advanced Pancreatic Cancer Receiving Palliative Chemotherapy: Incidence and Effect on Prognosis.
    Jeong HT; Bae JH; Kim HG; Han J
    Korean J Gastroenterol; 2023 Mar; 81(3):109-120. PubMed ID: 36960693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The survival detriment of venous thromboembolism with epithelial ovarian cancer.
    Gunderson CC; Thomas ED; Slaughter KN; Farrell R; Ding K; Farris RE; Lauer JK; Perry LJ; McMeekin DS; Moore KN
    Gynecol Oncol; 2014 Jul; 134(1):73-7. PubMed ID: 24793732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma.
    Barrau M; Maoui K; Le Roy B; Roblin X; Mismetti P; Phelip JM; Williet N
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3447-3454. PubMed ID: 33715087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
    Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
    J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer.
    Vergati M; Della-Morte D; Ferroni P; Cereda V; Tosetto L; La Farina F; Guadagni F; Roselli M
    Rejuvenation Res; 2013 Jun; 16(3):224-31. PubMed ID: 23521603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
    Kuderer NM; Culakova E; Lyman GH; Francis C; Falanga A; Khorana AA
    Oncologist; 2016 Jul; 21(7):861-7. PubMed ID: 27125754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients.
    Gonzalez-Billalabeitia E; Castellano D; Sobrevilla N; Guma J; Hervas D; Luengo MI; Aparicio J; Sanchez-Muñoz A; Mellado B; Saenz A; Valverde C; Fernandez A; Margeli M; Duran I; Fernandez S; Sastre J; Ros S; Maroto P; Manneh R; Cerezuela P; Carmona-Bayonas A; Ayala de la Peña F; Luis Aguilar J; Rivera S; García Del Muro X; Germà-Lluch JR;
    J Natl Cancer Inst; 2017 Jan; 109(4):. PubMed ID: 28122896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
    Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
    Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma.
    Ouaissi M; Frasconi C; Mege D; Panicot-Dubois L; Boiron L; Dahan L; Debourdeau P; Dubois C; Farge D; Sielezneff I
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):436-42. PubMed ID: 26256090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies.
    Shah MA; Capanu M; Soff G; Asmis T; Kelsen DP
    J Thromb Haemost; 2010 Aug; 8(8):1702-9. PubMed ID: 20553384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
    Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
    Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the 'SENDO experience'.
    Mandala M; Clerici M; Corradino I; Vitalini C; Colombini S; Torri V; De Pascale A; Marsoni S
    Ann Oncol; 2012 Jun; 23(6):1416-21. PubMed ID: 22052988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative venous thromboembolism predicts survival in cancer patients.
    Auer RA; Scheer AS; McSparron JI; Schulman AR; Tuorto S; Doucette S; Gonsalves J; Fong Y
    Ann Surg; 2012 May; 255(5):963-70. PubMed ID: 22504195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism in metastatic pancreatic cancer.
    Laderman L; Sreekrishnanilayam K; Pandey RK; Handorf E; Blumenreich A; Sorice KA; Lynch SM; Cheema K; Nagappan L; Sosa IR; Dotan E; Vijayvergia N
    Eur J Haematol; 2023 Jun; 110(6):706-714. PubMed ID: 36941225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Tumor Thrombus on Occurrence of Distant Venous Thromboembolism and Survival in Patients With Renal Cell Carcinoma After Surgery.
    Park H; Jeong CW; Yuk H; Ku JH; Kim HH; Kwak C; Kim I
    Clin Appl Thromb Hemost; 2019; 25():1076029618823288. PubMed ID: 30808214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.